Exodus Point Capital Management, LP Amneal Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.36 - $7.11 $600,153 - $796,099	111,969 New	111,969 $711,000
Q3 2023 Nov 09, 2023	BUY	$2.76 - $4.59 $131,055 - $217,951	47,484 New	47,484 $200,000
Q1 2022 May 13, 2022	SELL	$3.9 - $4.89 $90,838 - $113,897	-23,292 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.95 - $5.85 $92,003 - $136,258	23,292 New	23,292 $112,000
Q3 2021 Nov 15, 2021	SELL	$4.31 - $5.64 $181,157 - $237,060	-42,032 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.12 - $6.82 $215,203 - $286,658	42,032 New	42,032 $215,000

184

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.18B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.